US-based Alkomex to expand its R&D presence in India
ECONOMY & POLICY

US-based Alkomex to expand its R&D presence in India

Global pharmaceutical company Alkomex GBN is planning to expand its research and development presence in India by partnering with nutraceuticals expert Sanjay Agrawal to lead its strategic initiatives in the country.

Alkomex GBN has announced its collaboration with Dr. Sanjay Agrawal, a prominent Indian expert in health management and nutraceuticals, appointing him as the Scientific Advisor for the company.

Alex Meneses Vega, the CEO of Alkomex, mentioned that Agrawal’s leadership would be crucial in driving the company’s growth as it expands its presence in the nutraceutical and functional food sectors.

Agrawal will be based in Ahmedabad and will lead the company’s research and strategic efforts in India. He is expected to guide Alkomex’s R&D initiatives and integrate Indian research into the company's global operations.

The partnership is anticipated to strengthen Alkomex GBN’s ability to develop scientifically-backed nutraceuticals and functional food products aimed at improving global health and wellness, the company stated.

Nutraceuticals are foods, ingredients, or dietary supplements that may offer health or medical benefits.

Global pharmaceutical company Alkomex GBN is planning to expand its research and development presence in India by partnering with nutraceuticals expert Sanjay Agrawal to lead its strategic initiatives in the country. Alkomex GBN has announced its collaboration with Dr. Sanjay Agrawal, a prominent Indian expert in health management and nutraceuticals, appointing him as the Scientific Advisor for the company. Alex Meneses Vega, the CEO of Alkomex, mentioned that Agrawal’s leadership would be crucial in driving the company’s growth as it expands its presence in the nutraceutical and functional food sectors. Agrawal will be based in Ahmedabad and will lead the company’s research and strategic efforts in India. He is expected to guide Alkomex’s R&D initiatives and integrate Indian research into the company's global operations. The partnership is anticipated to strengthen Alkomex GBN’s ability to develop scientifically-backed nutraceuticals and functional food products aimed at improving global health and wellness, the company stated. Nutraceuticals are foods, ingredients, or dietary supplements that may offer health or medical benefits.

Next Story
Infrastructure Urban

TBO Tek Q2 Profit Climbs 12%, Revenue Surges 26% YoY

TBO Tek Limited one of the world’s largest travel distribution platforms, reported a solid performance for Q2 FY26 with a 26 per cent year-on-year increase in revenue to Rs 5.68 billion, reflecting broad-based growth and improving profitability.The company recorded a Gross Transaction Value (GTV) of Rs 8,901 crore, up 12 per cent YoY, driven by strong performance across Europe, MEA, and APAC regions. Adjusted EBITDA before acquisition-related costs stood at Rs 1.04 billion, up 16 per cent YoY, translating into an 18.32 per cent margin compared to 16.56 per cent in Q1 FY26. Profit after tax r..

Next Story
Infrastructure Energy

Northern Graphite, Rain Carbon Secure R&D Grant for Greener Battery Materials

Northern Graphite Corporation and Rain Carbon Canada Inc, a subsidiary of Rain Carbon Inc, have jointly received up to C$860,000 (€530,000) in funding under the Canada–Germany Collaborative Industrial Research and Development Programme to develop sustainable battery anode materials.The two-year, C$2.2 million project aims to transform natural graphite processing by-products into high-performance, battery-grade anode material (BAM). Supported by the National Research Council of Canada Industrial Research Assistance Programme (NRC IRAP) and Germany’s Federal Ministry for Economic Affairs a..

Next Story
Infrastructure Urban

Antony Waste Q2 Revenue Jumps 16%; Subsidiary Wins Rs 3,200 Cr WtE Projects

Antony Waste Handling Cell Limited (AWHCL), a leading player in India’s municipal solid waste management sector, announced a 16 per cent year-on-year increase in total operating revenue to Rs 2.33 billion for Q2 FY26. The growth was driven by higher waste volumes, escalated contracts, and strong operational execution.EBITDA rose 18 per cent to Rs 570 million, with margins steady at 21.6 per cent, while profit after tax stood at Rs 173 million, up 13 per cent YoY. Revenue from Municipal Solid Waste Collection and Transportation (MSW C&T) reached Rs 1.605 billion, and MSW Processing re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement